Edmond de Rothschild Holding’s Aurinia Pharmaceuticals AUPH Stock Holding History

Edmond de Rothschild Holding’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$169K	–	574
2025 Q2	$169K	Hold	20,000	–	–	﹤0.01%	390
2025 Q1	$161K	Hold	20,000	–	–	﹤0.01%	397
2024 Q4	$180K	Hold	20,000	–	–	﹤0.01%	413
2024 Q3	$147K	Hold	20,000	–	–	﹤0.01%	442
2024 Q2	$114K	Hold	20,000	–	–	﹤0.01%	478
2024 Q1	$100K	Hold	20,000	–	–	﹤0.01%	512
2023 Q4	$180K	Hold	20,000	–	–	﹤0.01%	441
2023 Q3	$155K	Hold	20,000	–	–	﹤0.01%	442
2023 Q2	$194K	Sell	20,000 -10,000	-33%	-$104K	﹤0.01%	442
2023 Q1	$329K	Buy	30,000 +10,000	+50%	+$88.1K	0.01%	397
2022 Q4	$86.4K	Hold	20,000	–	–	﹤0.01%	580
2022 Q3	$150K	Hold	20,000	–	–	﹤0.01%	513
2022 Q2	$201K	Hold	20,000	–	–	﹤0.01%	484
2022 Q1	$248K	Hold	20,000	–	–	0.01%	467
2021 Q4	$457K	Hold	20,000	–	–	0.01%	430
2021 Q3	$443K	Buy	20,000 +15,000	+300%	+$238K	0.01%	441
2021 Q2	$65K	Buy	+5,000	New	+$63.7K	﹤0.01%	657

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Edmond de Rothschild Holding's AUPH Position: Q3 2025 in Review

Edmond de Rothschild Holding sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2025, closing a stake of 20,000 shares — an estimated $169K sold.

Edmond de Rothschild Holding first reported a position in AUPH in Q2 2021 and held it in 17 quarters. The position peaked at $457K in Q4 2021. 242 funds tracked by Wall St. Rank hold AUPH as of Q3 2025.

Edmond de Rothschild Holding reported no remaining Aurinia Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Edmond de Rothschild Holding sold 20,000 Aurinia Pharmaceuticals shares in Q3 2025, an estimated $169K.
Edmond de Rothschild Holding first reported a position in Aurinia Pharmaceuticals in Q2 2021 and held it in 17 quarters.
Edmond de Rothschild Holding's Aurinia Pharmaceuticals position peaked at $457K in Q4 2021.
242 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2025.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2025, filed 13 Nov 2025.